Use cautionMedical device recall · FDA · Published June 23, 2025
HeartMate Mobile Power Unit AC Power Cord Recall: Misaligned V-Lock Risk
HeartMate recalls Mobile Power Unit AC Power Cord model 107760 due to misaligned V-Lock feature causing unintended disconnect. Affected patients should check if their device uses this model.
Due to misaligned V-Lock feature on the Mobile Power Unit power cords, which prevents the locking mechanism from properly engaging with the Mobile Power Unit and may cause unintended disconnect.
Take action
Contact the company
📍Recalling firmThoratec LLC6035 Stoneridge Dr · Pleasanton, CA 94588-3270
✎ GovInfoNow plain-language explainer
HeartMate is recalling its Mobile Power Unit AC Power Cord model 107760 because the V-Lock feature may not lock properly, causing the cord to disconnect unexpectedly. This could lead to the device losing power during critical medical use, potentially causing harm to patients with heart failure. Read more at govinfonow.com/recall/51980-heartmate-mobile-power-unit-ac-power-cord-recall-misaligned-v.
“HeartMate Mobile Power Unit AC Power Cord Recall: Misaligned V-Lock Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/51980-heartmate-mobile-power-unit-ac-power-cord-recall-misaligned-v. Based on FDA recall #Z-2290-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2290-2025%22&limit=1).
Thoratec LLC voluntarily recalled the HeartMate Mobile Power Unit AC Power Cord (Model 107760) due to a misaligned V-Lock feature that may cause unintended disconnect, the FDA said on June 23, 2025.
How to tell if you have it
Brand: HeartMate
Product Name: Mobile Power Unit, AC Power Cord
Model/Catalog Number: 107760
Lot Code: US Model No 107760
UDI-DI: 05415067038258
The hazard
The misaligned V-Lock feature on the Mobile Power Unit power cords prevents the locking mechanism from properly engaging with the Mobile Power Unit, which may cause unintended disconnect.
Context
Thoratec LLC has issued five other recalls since June 25, 2024, including a May 13, 2026 recall of HeartMate 11V Backup Batteries for failure risks and an Oct. 10, 2025 recall of the Thoratec CentriMag Blood Pump because it may not securely lock into the motor. Other recent recalls of similar products include a March 13, 2026 AVID Medical Halyard CARDIAC CATH PACK SAN23CARDQ Kit for loose connection risks and a May 21, 2026 Bard PowerPICC Catheters recall for defective lidocaine ampoules.
How to tell if you have this one
Check for the model number 107760 on the AC Power Cord label. The Mobile Power Unit is part of the HeartMate 3" Left Ventricular Assist System (LVAS) used for patients with advanced heart failure.
Brand
HeartMate
Category
Medical device
FDA recall event · 2 products
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
Classification
Class I
Status
Ongoing
Distribution
Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NM, NY, OH, OK, PA, SC, TN, TX, UT, VA, WA, WI, WV and the countries of Canada, Japan.
Recall number
Product, codes & lots
Quantity
Z-2290-2025
Brand Name: HeartMate Product Name: Mobile Power Unit, AC Power Cord Model/Catalog Number: 107760 Software Version: N/A Product Description: The HeartMate 3" Left Ventricular Assist System (LVAS) is a set of equipment and materials that together comprise a medical device designed to provide therapeutic benefit to those affected with advanced heart failure. In service, the LVAS assumes some or all of the workload of the left ventricle, thereby restoring the patient's systemic perfusion while palliating the underlying pathology. The LVAS features a Left Ventricular Assist Device (LVAD), a blood pump intended for long-term implantation in such patients, an extracorporeal Controller, plus all of the features, controls, attachments, interfaces, power sources, supporting equipment, labeling, and tools required to achieve the desired therapeutic benefit. The HeartMate II Left Ventricular Assist System is an axial-flow, rotary ventricular assist system that generates flows up to 10 liters per minute (lpm). One end of the Left Ventricular Assist Device is attached to the apex of the left ventricle; the other end of the device connects to the ascending aorta. The Left Ventricular Assist Device diverts blood from the weakened left ventricle and propels it to the aorta. A small external computer, the System Controller, monitors system operation. A driveline, which passes through the patient s abdomen, connects the implanted pump to the System Controller. The system is powered by a Power Module or Mobile Power Unit (MPU) that is connected to an AC electrical outlet, or by two HeartMate 14 Volt Lithium-Ion batteries. The LVAS may be used in any of two configurations. First, line power may be utilized through the Power Module or the Mobile Power Unit (MPU) to run the LVAD indefinitely, convenient for sedentary or sleeping periods. Second, portable Battery power may be utilized for limited periods, convenient for active periods. The MPU AC power cord is distributed either as part of the complete MPU device package or as a standalone accessory. (Labeling - Attachments E1 to E6) Component: Yes, the AC Power Cord is a component of the Mobile Power Unit; Lot Code: US Model No 107760; UDI-DI 05415067038258, For Lot Numbers, see Attachment F.
53
Z-2291-2025
Brand Name: HeartMate Product Name: Mobile Power Unit Model/Catalog Number: 107754 Software Version: N/A Product Description: The HeartMate 3" Left Ventricular Assist System (LVAS) is a set of equipment and materials that together comprise a medical device designed to provide therapeutic benefit to those affected with advanced heart failure. In service, the LVAS assumes some or all of the workload of the left ventricle, thereby restoring the patient's systemic perfusion while palliating the underlying pathology. The LVAS features a Left Ventricular Assist Device (LVAD), a blood pump intended for long-term implantation in such patients, an extracorporeal Controller, plus all of the features, controls, attachments, interfaces, power sources, supporting equipment, labeling, and tools required to achieve the desired therapeutic benefit. The HeartMate II Left Ventricular Assist System is an axial-flow, rotary ventricular assist system that generates flows up to 10 liters per minute (lpm). One end of the Left Ventricular Assist Device is attached to the apex of the left ventricle; the other end of the device connects to the ascending aorta. The Left Ventricular Assist Device diverts blood from the weakened left ventricle and propels it to the aorta. A small external computer, the System Controller, monitors system operation. A driveline, which passes through the patient s abdomen, connects the implanted pump to the System Controller. The system is powered by a Power Module or Mobile Power Unit (MPU) that is connected to an AC electrical outlet, or by two HeartMate 14 Volt Lithium-Ion batteries. The LVAS may be used in any of two configurations. First, line power may be utilized through the Power Module or the Mobile Power Unit (MPU) to run the LVAD indefinitely, convenient for sedentary or sleeping periods. Second, portable Battery power may be utilized for limited periods, convenient for active periods. The MPU AC power cord is distributed either as part of the complete MPU device package or as a standalone accessory. Component: Yes, the MPU is a component of the HeartMate 3 and HeartMate II Left Ventricular Assist Systems.; Lot Code: US Model No 107754; UDI-DI 05415067038234 Serial Numbers, see Attachment F.
604
Based on the official FDA remedy
What to do — step by step
Check Power Cord Model
Look for the model number 107760 on the AC Power Cord label to confirm if it is affected.
Ensure Proper Connection
If the cord is affected, make sure the V-Lock engages fully before using the device to prevent unintended disconnects.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 38 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NM, NY, OH, OK, PA, SC, TN, TX, UT, VA, WA, WI, WV and the countries of…” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin.
Recall timeline
FDA published this recall 58 days after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-2290-2025 (June 23, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2290-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.